6-K

 

FORM 6-K
U.S. SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 OF THE
SECURITIES EXCHANGE ACT OF 1934

dated February 13, 2019

Commission File Number 1-15148

BRF S.A.
(Exact Name as Specified in its Charter)

N/A(Translation of Registrant’s Name)

1400 R. Hungria, 5th FloorJd América-01455000-São Paulo – SP, Brazil(Address of principal executive offices) (Zip code)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F x   Form 40-F o

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T
Rule 101(b)(1): 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T
Rule 101(b)(7): 

Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes o   No x

If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): Not applicable.

 

*             *             *

This material includes certain forward-looking statements that are based principally on current expectations and on projections of future events and financial trends that currently affect or might affect the Company’s business, and are not guarantees of future performance.  These forward-looking statements are based on management’s expectations, which involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are beyond the Company’s control and any of which could cause actual financial condition and results of operations to differ materially fom those set out in the Company’s forward-looking statements.  You are cautioned not to put undue reliance on such forward-looking statements.  The Company undertakes no obligation, and expressly disclaims any obligation, to update or revise any forward-looking statements.  The risks and uncertainties relating to the forward-looking statements in this Report on Form 6-K, including Exhibit 1 hereto, include those described under the captions “Forward-Looking Statements” and “Item 3. Key Information — D. Risk Factors” in the Company’s annual report on Form 20-F for the year ended December 31, 2012.

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: February 13, 2019
	BRF S.A.
	By:	/s/ Elcio Ito
		Name:	Elcio Ito
		Title:	Chief Financial and Investor Relations Officer

 

EXHIBIT INDEX

Exhibit	Description of Exhibit
1	ANNOUNCEMENT TO THE MARKET

EX-1

 

BRF S.A.

PUBLICLY-HELD COMPANY

CNPJ 01.838.723/0001-27

NIRE 42.300.034.240

CVM 16269-2

ANNOUNCEMENT TO THE MARKET

BRF S.A. ("BRF" or "Company") (B3: BRFS3; NYSE: BRFS) informs to its shareholders and the market in general that, on February 13, 2019, it announced a recall of approximately 164.7 metric tons of fresh chicken meat destined to the Brazilian domestic market (Portuguese only), as well as a precautionary removal of approximately 299.6 metric tons of fresh chicken meat  destined to the international market, and produced on October 30, 2018 and on November 05, 06, 07, 09, 10, and 12, 2018, exclusively at its manufacturing unit in Dourados-MS (SIF 18), due to a potential presence of Salmonella enteritidis in products produced on the dates referred above.

The decision to recall all the batches, instead of the affected parts of the production, follows the precautionary principle and BRF's commitment with Food Safety, Quality, and Transparency. The Company has already proactively started the inventory and collection of the products either en route or with its clients in the domestic and international markets, as well as:

(i)deployed a group of specialists to investigate the origins of this sole case to ensure thatthe appropriate measures are taken to avoid reoccurrence;

(ii)maintains the production of -MS plant under a rigorous hold and release process of products to guarantee that the occurrence was a sole event and  that it will not repeat.

Additionally, the incident and the collection of the products were formally reported to the Brazilian authorities, among them, the Ministry of Agriculture, Livestock, and Supply – MAPA and the National Health Surveillance Agency – ANVISA, having agreed with the latter the basis of the voluntary recall.

It is worth highlighting that the Salmonella bacteria do not resist to heat treatment, meaning that the traditional cooking processes are enough to eliminate any potential hazard caused by the bacteria presence.

The Company will keep its shareholders and the market in general duly informed about any development regarding the present Announcement.

São Paulo, February 13, 2019.

Elcio Ito

Chief Financial and Investor Relations Officer